Together, these medications form a powerful synergy, offering comprehensive blood pressure control in a single pill. Clinical evidence Groundbreaking studies highlight the efficacy of GMRx2.

A revolutionary new blood pressure pill is being trialled which could dramatically transform the lives of people living with hypertension. GMRx2 is a ‘3-in-1’ drug which combines doses of ...

The Gemini Study was a 14-week, open-label, non-comparative, office-based, multicenter trial to evaluate single-pill therapy in the treatment of concomitant hypertension and dyslipidemia. In ...

WIDAPLIK™, a newly FDA-approved triple combo pill, promises better blood pressure control for adults, including those starting hypertension treatment for the first time.

Phase III trial results of novel triple combination pill for hypertension published in The Lancet Novel combination pill significantly reduced blood pressure and improved control rates vs dual ...

For the main secondary end point of mean 24-hour ambulatory systolic BP, there was a significant difference for the quadruple single pill versus the triple group (−7.53 mm Hg); in addition ...

WEDNESDAY, Sept. 4, 2024 (HealthDay News) -- An experimental three-in-one blood pressure pill works better than layering on meds one at a time, a new clinical trial shows.

At month 6, in the triple-pill and standard-care protocols, clinical blood pressure control was 82 and 72%, respectively, and home blood pressure control was 62 vs 28%, respectively.

Research Highlights: A study of three pills that combined two types of blood-pressure-lowering medications into one pill found that all combinations worked equally well among adults in India.